Popular GLP-1 medications used to treat type 2 diabetes and obesitysemaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound)may be linked to a small increase in the risk of a rare eye condition that can cause sudden vision loss, according to new research
Typically, being at or near your goal weight can improve your overall results, especially for procedures like tummy tucks or body lifts
Its no secret that weight-loss medications, particularly those of the injectable variety, are in high demand
Structured exercise, adequate sleep, and targeted use of probiotics and selected nutraceuticals provide additional, evidence-informed levers to complement pharmacological GLP-1RAs or to support metabolic health in individuals who are not using these medications
Many so-called "overdoses" aren't simply patient mistakes